Uber Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 15-11-2024
- Paid Up Capital ₹ 1.78 M
as on 15-11-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 15-11-2024
- Revenue -45.07%
(FY 2023)
- Profit -2074.78%
(FY 2023)
- Ebitda -3993.47%
(FY 2023)
- Net Worth -3819.85%
(FY 2023)
- Total Assets -27.54%
(FY 2023)
About Uber Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.78 M.
The company currently has active open charges totaling ₹1.00 Cr.
Girish Narasimhan, Ashim Kumar, Avin Agarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110KA2014PTC073658
- Company No.
073658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2014
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
What products or services does Uber Diagnostics Private Limited offer?
Uber Diagnostics Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, ECG Machine, Medical Laboratory Instruments, Rapid Test Kit.
Who are the key members and board of directors at Uber Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Narasimhan  | Director | 02-Jul-2024 | Current |
| Ashim Kumar | Director | 14-Feb-2014 | Current |
| Avin Agarwal | Director | 14-Feb-2014 | Current |
| Dinesh Kamath | Director | 02-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Uber Diagnostics.
Uber Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 45.07% decrease. The company also saw a substantial fall in profitability, with a 2074.78% decrease in profit. The company's net worth observed a substantial decline by a decrease of 3819.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uber Diagnostics?
In 2023, Uber Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2022 | ₹4.00 M | Open |
Others Creation Date: 03 Sep 2021 | ₹2.00 M | Open |
Canara Bank Creation Date: 10 Jul 2014 | ₹4.00 M | Open |
How Many Employees Work at Uber Diagnostics?
Uber Diagnostics has a workforce of 39 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uber Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uber Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
